Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Niven Mehra



Radboud University Medical Center

Dr Niven Mehra is Consultant in Medical Oncology at the Radboud University, Nijmegen, The Netherlands.

He studied Medicine at the University Medical Center Utrecht where he graduated in 2002. He completed a PhD in translational research in 2006 (under Emile Voest), followed by training in Internal Medicine from 2006 to 2011 and in Medical Oncology from 2011 to 2014.

In 2014 he focused on urogenital oncology during a Clinical Research Fellowship at the Royal Marsden NHS Trust and the Institute of Cancer Research (under Johann de Bono) where he was a sub-investigator for clinical trials in the Prostate Targeted Therapy Group. His post-doctorate research at the Institute of Cancer Research is focused on biomarkers discovery in liquid biopsies using next-generation sequencing techniques, and on the role of immune suppressive cells driving treatment resistance in prostate cancer.

Niven Mehra is member of the Educational Publications Working Group of the European Society for Medical Oncology (ESMO), and author of several peer-reviewed research papers in international journals, cancer text- and handbooks.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.